tiprankstipranks
Cabaletta Bio (CABA)
NASDAQ:CABA
US Market
Holding CABA?
Track your performance easily

Cabaletta Bio (CABA) Income Statement

639 Followers

Cabaletta Bio Income Statement

Last quarter (Q3 2024), Cabaletta Bio's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Cabaletta Bio's net income was $-30.63M. See Cabaletta Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
------
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 114.50M$ 74.66M$ 54.14M$ 46.31M$ 33.83M$ 18.68M
Operating Income
$ -114.50M$ -74.66M$ -54.14M$ -46.31M$ -33.83M$ -18.68M
Net Non Operating Interest Income Expense
$ 10.34M$ 6.99M$ 1.16M$ 24.00K$ 494.00K$ 1.74M
Other Income Expense
$ -5.04M$ -5.10M$ 47.00K$ 6.00K$ -6.00K$ 5.33M
Pretax Income
$ -104.16M$ -67.67M$ -52.98M$ -46.29M$ -33.34M$ -22.27M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
-----$ -5.33M
Net Income Common Stockholders
$ -105.55M$ -67.67M$ -52.98M$ -46.29M$ -33.34M$ -22.27M
Basic EPS
$ -2.15$ -1.65$ -1.81$ -1.80$ -1.44$ -4.07
Diluted EPS
$ -2.16$ -1.65$ -1.81$ -1.80$ -1.44$ -4.07
Basic Average Shares
$ 18.65M$ 1.17M$ 5.94M$ 25.72M$ 23.15M$ 5.47M
Diluted Average Shares
$ 18.65M$ 1.17M$ 5.94M$ 25.72M$ 23.15M$ 5.47M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 114.50M$ 74.66M$ 54.14M$ 46.31M$ 33.83M$ 18.68M
Net Income From Continuing And Discontinued Operation
$ -104.16M$ -67.67M$ -52.98M$ -46.29M$ -33.34M$ -22.27M
Normalized Income
$ -74.15M$ -53.46M-$ -36.57M--
Interest Expense
------
EBIT
$ -109.41M$ -74.66M$ -54.14M$ -46.31M$ -33.83M$ -22.27M
EBITDA
$ -107.21M$ -73.23M$ -52.96M$ -45.58M$ -33.48M$ -22.16M
Currency in USD

Cabaletta Bio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis